MentionFox
Home › Executive changes › Integra Lifesciences Holdings Corp
Leadership changes · IART · SEC Form 8-K, Item 5.02

Leadership changes at Integra Lifesciences Holdings Corp (2026)

Before you join, sell to or invest in Integra Lifesciences Holdings Corp

MentionFox check on Integra Lifesciences Holdings Corp: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/integra-lifesciences-holdings

Check Integra Lifesciences Holdings Corp before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Integra Lifesciences Holdings Corp?

Who joined and who left Integra Lifesciences Holdings Corp (IART)? 1 appointment reported on 2026-05-05, each cited to the company's own filing.

Michael McBreen was named Chief Commercial Officer of Integra Lifesciences Holdings Corp. As of November 15, 2026, Integra Lifesciences Holdings Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on May 5, 2026, naming 1 appointment (Form 8-K, May 5, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

PARADIGM CAPITAL MANAGEMENT INC/NY also filed stake reports on 7 other companies ↓

Sell to companies like Integra Lifesciences Holdings Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
In (appointed)1
Latest filing2026-05-05

Integra Lifesciences Holdings Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-05. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Integra Lifesciences Holdings Corp files it.

Also on the record for Integra Lifesciences Holdings Corp

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G, by Invesco Ltd.5.4% of the class5%+ stakesSource
August 13, 2026Stake report, Schedule 13G/A, by PARADIGM CAPITAL MANAGEMENT INC/NY—5%+ stakesSource
July 31, 2026Stake report, Schedule 13G, by Vanguard Portfolio Management5.02% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G, by PARADIGM CAPITAL MANAGEMENT INC/NY5.2% of the class5%+ stakesSource
March 27, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by Fuller & Thaler Asset Management, Inc.4.67% of the class5%+ stakesSource
November 6, 2025Stake report, Schedule 13G/A, by Invesco Ltd.4.5% of the class5%+ stakesSource
August 5, 2025Stake report, Schedule 13G/A, by Morgan Stanley4.3% of the class5%+ stakesSource
July 17, 2025Stake report, Schedule 13G/A, by BlackRock, Inc.13.2% of the class5%+ stakesSource
July 9, 2025Stake report, Schedule 13G/A, by Rubric Capital Management LP9.46% of the class5%+ stakesSource

Selling to them or working with them? See who runs Integra Lifesciences Holdings Corp now and the warning signs.

Watch Integra Lifesciences Holdings Corp: email me the next time it files something

Free to see. No signup.

Keep reading

More on Integra Lifesciences Holdings Corp and the records around it.

Integra Lifesciences Holdings Corp elsewhere on the record

Companies that share a holder

Want the whole picture on Integra Lifesciences Holdings Corp?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Integra Lifesciences Holdings Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Integra Lifesciences Holdings Corp covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    11 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-05-05InChief Commercial Officer8-K, 2026-05-05

Who leads Integra Lifesciences Holdings Corp, as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Integra Lifesciences Holdings Corp?

New leaders reset buying decisions — get the Full Report on Integra Lifesciences Holdings Corp: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Integra Lifesciences Holdings Corp

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Commercial Officer at Integra Lifesciences Holdings Corp, with the record behind each one.

Find candidates like Chief Commercial Officer at Integra Lifesciences Holdings Corp

Every change, in the filing's words

Filed 2026-05-05 · 8-K

Appointed: Michael McBreen, Chief Commercial Officer

On May 5, 2026, the Company also announced the appointment of Michael McBreen, the Company's Executive Vice President, President, Codman Specialty Surgical, as Chief Commercial Officer effective as of the Start Date.

Also stated in this filing

  • Appointment of Dr. Stuart Essig as President and Chief Executive Officer On May 5, 2026, Integra LifeSciences Holdings Corporation (the "Company") announced the appointment of Dr. Stuart M. Essig to serve as its President and Chief Executive Officer, effective as of May 1, 2026 (the "Start Date").
  • Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the "Board") effective as of the end of the day on April 30, 2026 (the "Separation Date").
  • Dr. Essig, 64, has served as Chairman of the Board since January 2012 and will continue to serve in such role following his appointment as President and Chief Executive Officer.
  • Prior to serving as Chairman, he served as the Company's Chief Executive Officer and as a director from 1997 through 2012 and as the Company's President from 1997 until 2010.
  • From February 2024 to June 2025, he served as the Executive Chairman of the Board.
  • Prior to joining the Company, he acted as the managing director in mergers and acquisitions for the medical technology practice at Goldman, Sachs & Co. He currently serves as managing director of Prettybrook Partners, LLC, a family office dedicated to investing in healthcare companies, which he cofounded in 2012.

Tools for this story

Each opens in a new tab, filled in for Integra Lifesciences Holdings Corp. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/integra-lifesciences-holdings
Last updated 2026-11-15
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who joined Integra Lifesciences Holdings Corp? (2026). MentionFox, 2026-11-15. https://mentionfox.com/executive-changes/integra-lifesciences-holdings